Company / Return on Equity (ROE)
CME Group Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
14.2%
FY2025
5-year range
9.6% / 14.2%
FY2021-FY2025
Trend
+6.5%
vs FY2024
Sector context
#118 of 387
Financials
What the data says
At 14.2%, CME Group's return on equity (roe) ranks #118 of 387 in the Financials sector. Return on Equity (ROE) has increased for 5 consecutive years, from 7.5% in FY2020 to 14.2% in FY2025.
Based on SEC 10-K filings.
14.2% in FY2025 with a 5-year CAGR of +6.7%.
Improved from 12.1% to 14.2% over the past 2 years.
Financials sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +4.2pp
- 5-Year Change
- +6.7pp
- 10-Year Change
- -
Sector benchmark
#118 of 387 in FinancialsTop 30% of 387This company 14.2% Sector average 17.3%
▼
-18.2% below sector average
Key checks
Key Insights
- CME Group's return on equity (roe) has grown for 5 consecutive years.
- In FY2025, return on equity (roe) increased 6.5% year-over-year.
- Currently 3.2pp below the Financials sector average.
- Peak return on equity (roe) was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.2% | +6.5% |
| FY2024 | 13.3% | +10.3% |
| FY2023 | 12.1% | +20.6% |
| FY2022 | 10.0% | +4.1% |
| FY2021 | 9.6% | +28.1% |
| FY2020 | 7.5% | -52.1% |
| FY2019 | 15.7% | +107.4% |
| FY2018 | 7.6% | -58.3% |
| FY2017 | 18.1% | +140.5% |
| FY2016 | 7.5% | +24.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026